Bo Zhang
- Nephrology top 0.5%
- Renal Diseases and Glomerulopathies 22
- Chronic Kidney Disease and Diabetes 20
- Parathyroid Disorders and Treatments 11
- Cancer Research top 1%
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 28
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 17
- Diabetes Treatment and Management 12
- Immunology top 2%
-
- Metabolism, Diabetes, and Cancer 11
- Epigenetics and DNA Methylation 9
- Cited by
- NephrologyCancer ResearchOncology
- Journals
- Journal of Clinical Oncology (2 papers)SHILAP Revista de lepidopterología (5 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Bo Zhang
239 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Nephrology 698
- Cancer Research 1.1k
- Oncology 1.6k
- Endocrinology, Diabetes and Metabolism 857
- Immunology 931
Countries citing papers authored by Bo Zhang
This map shows the geographic impact of Bo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zhang more than expected).
Fields of papers citing papers by Bo Zhang
This network shows the impact of papers produced by Bo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zhang. The network helps show where Bo Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bo Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 52 | |
| 6 | 2023 | 1 | |
| 7 | Single-cell transcriptome analysis revealed a suppressive tumor immune microenvironment in EGFR mutant lung adenocarcinomabreakdown → | 2022 | 120 |
| 8 | 2021 | 3 | |
| 9 | 2021 | 31 | |
| 10 | 2019 | 120 | |
| 11 | 2019 | 33 | |
| 12 | 2018 | 11 | |
| 13 | Shading, cooling and humidifying effects of urban forests in Harbin City and possible association with various factors. | 2017 | 15 |
| 14 | 2016 | 5 | |
| 15 | 2016 | 14 | |
| 16 | 2015 | 23 | |
| 17 | 2015 | 12 | |
| 18 | Changes of T Regulatory Cells and Interleukin-10 in Children with Primary Nephrotic Syndrome before and after Treatment Assisted with Huaiqihuang Particles | 2011 | 2 |
| 19 | Oxidative Damage Effect on Kidney of Mice Induced by Sulfur Dioxide Inhalation | 2004 | 1 |
| 20 | The distributive characteristics of Jingyu mineral water field in the Changbaishan area, Jilin province and its suggestion for developmental strategy | 2001 | 2 |
About Bo Zhang
Bo Zhang is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Oncology, having authored 252 papers that have together received 6.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (28 papers), Renal Diseases and Glomerulopathies (22 papers), Chronic Kidney Disease and Diabetes (20 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers), Diabetes Treatment and Management (12 papers), Metabolism, Diabetes, and Cancer (11 papers), Parathyroid Disorders and Treatments (11 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Nephrology (698 citations), Cancer Research (1.1k citations) and Oncology (1.6k citations). Bo Zhang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Jin Xu, Xianjun Yu, Si Shi, Qingcai Meng, Chen Liang, Jie Hua, Jiang Liu, Wei Wang, Xiaoqi Mao and Yanggang Yuan. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.